# Derm-Maxx in Patients With Diabetic Foot Ulcers Unresponsive to Standard of Care Treatment Alone

> **NCT06455475** · NA · RECRUITING · sponsor: **Capsicure, LLC** · enrollment: 150 (estimated)

## Conditions studied

- Diabetic Foot Ulcer

## Interventions

- **OTHER:** Derm-Maxx

## Key facts

- **NCT ID:** NCT06455475
- **Lead sponsor:** Capsicure, LLC
- **Sponsor class:** NETWORK
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-25
- **Primary completion:** 2025-10-31
- **Final completion:** 2025-10-31
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2025-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06455475

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06455475, "Derm-Maxx in Patients With Diabetic Foot Ulcers Unresponsive to Standard of Care Treatment Alone". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06455475. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*